StockWatch
·
Pharmaceuticals
Quarterly Result28 May 2026, 07:12 pm

531398 FY26 Net Sales ₹70.38 Cr, Profit ₹4.92 Cr; CFO Resigns

AI Summary

531398 announced its audited financial results for the quarter and year ended March 31, 2026. For the full year FY26, Net Sales/Income from Operations reached ₹7,037.74 Lakhs, with Profit from Operations at ₹492.30 Lakhs. For Q4 FY26, Net Sales/Income from Operations was ₹2,102.94 Lakhs, and Profit from Operations was ₹201.13 Lakhs. The Board approved these results, noting an unmodified audit opinion. Additionally, Mr. R Ramachandra resigned as Chief Financial Officer and Key Managerial Personnel, effective May 31, 2026. The Board also approved the re-appointment of M/s Ganga Prakash & Co. as Internal Auditors and M/s Chiranjeevulu Jeelaga & Co. as Cost Auditors for the year 2026-27.

Key Highlights

  • FY26 Net Sales/Income from Operations stood at ₹7,037.74 Lakhs.
  • FY26 Profit from Operations was ₹492.30 Lakhs.
  • Q4 FY26 Net Sales/Income from Operations was ₹2,102.94 Lakhs.
  • Mr. R Ramachandra resigned as Chief Financial Officer effective May 31, 2026.
  • Internal and Cost Auditors were re-appointed for the year 2026-27.